Journal of Oncology Pharmacy Practice

Papers
(The H4-Index of Journal of Oncology Pharmacy Practice is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Alectinib continuation during COVID 19 ‘antiviral’ treatment: Risk or benefit?29
Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers26
Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice22
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients20
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant14
Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)12
Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer12
Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors12
A room of errors simulation to improve pharmacy operators’ knowledge of cytotoxic drug production12
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer12
Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center11
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient11
Hydroxyurea- a cost effective treatment in developing countries for Atypical Chronic Myeloid Leukemia (aCML): Case Report of Two Patients11
0.14494490623474